Neogenomics (NEO) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Neogenomics (NEO) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.60% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 20.61% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 54.28% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -7.61% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.84% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 19.26% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 14.23% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 6.98% |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | 75.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.49% |
| Mar 31, 2026 | -77.37% |
| Dec 31, 2025 | -97.64% |
| Sep 30, 2025 | -247.03% |
| Jun 30, 2025 | -287.61% |
| Mar 31, 2025 | 5.20% |
| Dec 31, 2024 | -2.55% |
| Sep 30, 2024 | 10.10% |
| Jun 30, 2024 | 21.41% |
| Mar 31, 2024 | 9.12% |
| Dec 31, 2023 | -118.41% |
| Sep 30, 2023 | 94.95% |
| Jun 30, 2023 | 60.92% |
| Mar 31, 2023 | 50.08% |
| Dec 31, 2022 | 41.03% |
| Sep 30, 2022 | -827.61% |
| Jun 30, 2022 | -72.90% |
| Mar 31, 2022 | -211.57% |
| Dec 31, 2021 | -439.83% |
| Sep 30, 2021 | -1,713.19% |